New Pneumococcal Vaccine Approved by the U.S. FDA
July 21, 2021
Mountain Pacific
The U.S. Food and Drug Administration (FDA) just approved a new vaccine for adults. PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) helps prevent invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes, or subgroups, in the vaccine and is recommended for adults age 18 years and older. Pneumococcal disease can include pneumonia, meningitis […]
Read More...
Pneumococcal Disease in Adults – How Can You Prevent It? Part 2
May 20, 2021
Mountain Pacific
In this blog, we learned about what pneumococcal disease is and how it spreads. Now, we will learn how we can help prevent the disease.
Which vaccines help prevent pneumococcal disease in adults?
There are two vaccines used in the United States to help prevent pneumococcal disease: PCV13 and PPSV23. In addition, getting an influenza (flu) vaccine […]
Read More...
Pneumococcal Disease in Adults – What Is It? How Does It Spread? Part 1
May 6, 2021
Mountain Pacific
According to the Centers for Disease Control and Prevention (CDC) pneumococcal pneumonia causes 150,000 hospitalizations each year in the United States. In 2018 alone, pneumococcal meningitis and bacteremia killed nearly 3,500 people. While pneumococcal disease in adults often ranges from mild to serious, the disease can be deadly. However, the disease is preventable. Two vaccines […]
Read More...
